PLC GATHERING ADDITIONAL FOLLOW-UP DATA FOR HEART LASER SYSTEM WITH EXPECTATION OF FALL SUBMISSION; FDA PANEL DEEMS DEVICE NOT APPROVABLE
This article was originally published in The Gray Sheet
Executive Summary
PLC Medical Systems is planning a fall submission to FDA of additional follow-up data for its Heart Laser System transmyocardial revascularization device.